Pre-approval Single-patient Expanded Access for Abrocitinib (PF-04965842)

Apremilast for Atopic Dermatitis - A Pilot Study in Adults

NCT01393158 ·Status: COMPLETED ·Phase: PHASE2

Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT06585202 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years And Older With Moderate to Severe Atopic Dermatitis

NCT03575871 ·Status: COMPLETED ·Phase: PHASE3

Effects of Abrocitinib in Subjects With Atopic Dermatitis With an Unsatisfactory Response After Treatment With Dupilumab

NCT05602207 ·Status: COMPLETED ·Phase: PHASE4

A Study Evaluating APG777 in Atopic Dermatitis

NCT06395948 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Pilot Efficacy and Safety Study of AQX-1125 in Atopic Dermatitis

NCT02324972 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis

NCT04668066 ·Status: COMPLETED ·Phase: PHASE1

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

NCT06807281 ·Status: RECRUITING ·Phase: PHASE3

Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

NCT03720470 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess Subcutaneous Lirentelimab (AK002) in Atopic Dermatitis

NCT05155085 ·Status: TERMINATED ·Phase: PHASE2

A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT05507580 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

NCT03568318 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

NCT07003425 ·Status: RECRUITING ·Phase: PHASE2

Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

NCT04345367 ·Status: COMPLETED ·Phase: PHASE3

Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)

NCT06353087 ·Status: RECRUITING

A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis

NCT06863961 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Drug Survival of Target Therapies in Atopic Dermatitis

NCT06882148 ·Status: RECRUITING

A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis

NCT05250115 ·Status: TERMINATED

A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic Dermatitis

NCT04256174 ·Status: COMPLETED ·Phase: PHASE1

A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

NCT05375955 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

NCT05601882 ·Status: COMPLETED ·Phase: PHASE3

Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis

NCT05048056 ·Status: TERMINATED ·Phase: PHASE2

Effect of OC000459 on Moderate to Severe Atopic Dermatitis

NCT02002208 ·Status: COMPLETED ·Phase: PHASE2

A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD)

NCT06881251 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis

NCT07223697 ·Status: RECRUITING ·Phase: PHASE2